Document is current
Any future updates will be listed below
-
Authors
Bollegala, Natasha
Barwick, Melanie
Fu, Nancy
Griffiths, Anne M.
Keefer, Laurie
Kohut, Sara Ahola
Kroeker, Karen I.
Lawrence, Sally
Lee, Kate
Mack, David R.
Walters, Thomas D.
de Guzman, Jacqueline
Tersigni, Claudia
Miatello, Ashleigh
Benchimol, Eric I. https://orcid.org/0000-0001-8855-3598
-
Funding
Funding for this research was provided by:
Crohn's and Colitis Canada
Leona M. and Harry B. Helmsley Charitable Trust (2103-05041)
CH.I.L.D. Foundation
- License Information
-
More Information
Article History
Received: 4 February 2022
Accepted: 28 April 2022
First Online: 18 May 2022
Declarations
:
: This study has been approved by the Research Ethics Boards of SickKids (1000078476) and CHEO (21/143X), and is under review by Research Ethics Boards from the other participating centers. In Canada, there is no ‘age of majority’ for medical treatment or research consent. Adolescents can consent to treatments and research if they are deemed competent and informed. Informed consent will be obtained from the adolescents by research staff.
: Not applicable.
: NB, MB, NF, SAK, KK, DRM, TDW, JG, CT, AM: Nothing to disclose. AMG: Has been consultant to Abbvie, Amgen, BristolMyersSquibb, Janssen, Lilly, Merck; has received speaker fees from Abbvie, Janssen, Nestle. LK: Consultant to Abbvie, Lilly, Takeda; equity owner and co-founder Trellus Health; Board of Directors, Rome Foundation. SL: Advisory board and speakers bureau for Abbvie and Janssen. KL: Participated on advisory panels for AbbVie, Janssen, Pfizer and Takeda. EIB: Acted as a legal consultant for Hoffman La-Roche Limited and Peabody & Arnold LLP for matters unrelated to a medication used to treat inflammatory bowel disease. Acted as a consultant for McKesson Canada and the Dairy Farmers of Ontario (no relation to this study). Chair of the Scientific and Medical Advisory Council of Crohn’s and Colitis Canada (co-sponsor of this study).
